iGMDRD50
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Cytarabine | CHEMBL803 CHEMBL1256472 | 6253 | D03637 | DB00987 | Alone | DNC001551 | Small Molecule |
Drug Class:
Anti-Infective AgentsAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntiviral AgentsArabinonucleosidesCarbohydratesCardiotoxic antineoplastic agentsCytidineGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesP-glycoprotein/ABCB1 SubstratesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesRibonucleosidesToxic ActionsDrug Pathways:
DNA replicationDrug Synonyms:
Cytarabine hydrochloride (USAN)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
7514 | XPO1 | 1 |
103 | ADAR | 1 |
64783 | RBM15 | 1 |
4170 | MCL1 | 1 |
9757 | KMT2B | 2 |
5159 | PDGFRB | 1 |
4851 | NOTCH1 | 1 |
25937 | WWTR1 | 1 |
2064 | ERBB2 | 1 |
6850 | SYK | 1 |
1029 | CDKN2A | 2 |
861 | RUNX1 | 1 |
7157 | TP53 | 1 |
2305 | FOXM1 | 1 |
4086 | SMAD1 | 1 |
57111 | RAB25 | 1 |
54658 | UGT1A1 | 1 |
7490 | WT1 | 1 |
675 | BRCA2 | 1 |
54894 | RNF43 | 1 |
6935 | ZEB1 | 1 |
10381 | TUBB3 | 1 |
7301 | TYRO3 | 1 |
2113 | ETS1 | 1 |
2648 | KAT2A | 2 |
2067 | ERCC1 | 2 |
9223 | MAGI1 | 1 |
5054 | SERPINE1 | 1 |
Gene in drug-gene network: Network Plot
Models in Cytarabine